期刊文献+

广西地区人群AGT基因多态性与2型糖尿病肾病关系的研究 被引量:2

Associations of AGT Gene Polymorphisms with Type 2 Diabetic Nephropathy in Guangxi People
下载PDF
导出
摘要 [目的]探讨血管紧张素原(AGT)基因M235T及T174M多态性是否与广西地区人群2型糖尿病肾病(DN)的发病有关。[方法]243例研究对象分为2型糖尿病病例组(DM组,n=107)和正常对照组(n=136);DM组根据有无并发肾病分为DN(+)组(n=53)与DN(-)组(n=54)。分别用突变基因分离聚合酶链反应(MS-PCR)和PCR-限制性片段长度多态性(PCR-RFLP)技术对AGT M235T及AGT T174M多态性进行检测。[结果]AGT基因M235T多态位点在DN(+)、DN(-)及正常对照组中均以TT型多见,分别为0.717,0.667,0.640;三组间基因型分布构成比比较及等位基因频率构成比比较均无显著性差异。三组间AGT T174M基因型构成比比较及等位基因频率构成比比较均无统计学意义。[结论]未发现AGT基因M235T或T174M多态性与广西地区2型DN的发生有关联。 [ Objective]To investigate whether or not AGT M235T and AGT T174M, two types of polymorphisms of AGT gene, are associated with type2 diabetic nephropathy (DN) in Guangxi people. [Methods]A case-control study was performed. 243 subjects from Guangxi were classified into a type 2 diabetes mellitus (DM) group ( n = 107) and a eontrol group ( n = 136). The former was subdivided into a DN( + ) group ( n = 53 ) and a DN( - ) group ( n = 54 ) according to with or without DN. The AGT M235 and AGT T174M polymorphisms were examed by mutagenically separated PCR (MS-PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP), respectively. [Results]The genotype found in AGT M235T polymorphic site was mostly TT type in three groups (0. 717, 0. 667 and 0.640, respectively). No significant differences in AGT M235T genotypes and allelic frequencies were observed among three groups. The AGT T174M polymorphism did not display any difference in allelic frequencies and genotype distribution among three groups. [ Conclusions] AGT M235T and AGT T174M are not associated with the development of DN in Guangxi patients with type 2 DM.
出处 《广西中医学院学报》 2007年第4期17-20,共4页 Journal of Guangxi Traditional Chinese Medical University
关键词 2型耱尿病 耱尿病肾病 血管紧张素原 基因多态性 广西地区 Type 2 diabetic mellitus Diabetic nephropathy Angiotensinogen Polymorphism Guangxi region
  • 相关文献

参考文献10

  • 1Bloem L J, Manamnga AK, Tewksburg DA, et al. The serum angiotensinogen eoncentration and variants of the angiotensinogen gene in white and black children[J]. J Clin Invest, 1995,93 : 948 - 953.
  • 2Wu S, Xiang K, Zheng T, et al. Relationship between the renin-anglotensln system genes and diabetic nephropathy in Chinese[ J ]. Chin Med J (Engl), 2000,113 (5) : 437 - 441.
  • 3Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensln system and nephropathy in type 2 diabetic patients[J]. Diabetes Metab, 2002,28 (1) : 27 - 32.
  • 4Beige J, Weber A, Engeli S, et al. Angiotensinogen-M235T genotype and posttransplant hyperterksion[J]. Nephrol Dial Transplant, 1996,11 : 1538 - 1541.
  • 5耿茜,杨笛,张寄南,马文珠.MS-PCR法检测血管紧张素原基因M235T多态性[J].江苏医药,2001,27(4):251-253. 被引量:2
  • 6Gutierrez C, Vendrell J, Pastor R, et al. Angiotensin converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian mediterranean population [J ]. Metabolism, 1997,46 (8) : 976 - 980.
  • 7Fogarty DG, Harron JC, Hughes AE, et al. A molecularvariant of angiotensinogen is associated with diabetic nephropathy in IDDM[J]. Diabetes, 1996, 45 (9) : 1204- 1208.
  • 8Tarow L, Cambien P, Rossing P, et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy[J]. Diabetes, 1996,45(3) :367- 369.
  • 9Zychma MJ, Zukowska SE, Lacka BI, et al. Angiotensinogen M235T and chymase gene CMA/B polymorphisms axe not associated with nephropathy in type II diabetes[J]. Nephrol Dial Transplant, 2000,15(12): 1965 - 1970.
  • 10Stephan R, Harald F, Gerd A. Mutagenically separated PCR(MS-PCR) : a highly specific one step procedure for easy mutation detection [J ]. Nucleic Acids Research, 1993,21:3623- 3629.

二级参考文献1

  • 1陈德,中华医学遗传学杂志,1998年,15卷,133页

共引文献1

同被引文献22

  • 1吴松华,项坤三,郑泰山,孙多奇,翁青,赵红华,李杰.Relationship between the renin angiotensin system genes and diabetic nephropathy in the Chinese[J].Chinese Medical Journal,2000(5):53-57. 被引量:6
  • 2林善锬.糖尿病肾病[J].中华内科杂志,2005,44(3):229-231. 被引量:117
  • 3刘广印,周光庭,沈佐君.实时荧光定量PCR检测巨细胞病毒两种白细胞提取方法对比分析[J].淮海医药,2007,25(2):95-96. 被引量:3
  • 4Kalantarinia K, Okusa M D. The reninangiotensin system and its blockade in diabetic renal and cardiovascular disease[ J]. Curr Diab Rep, 2006, 6(1) : 8-16.
  • 5Thomas MC, Atkins RC Blood pressure lowering for the prevention and treatment of diabetic kidney disease [ J ]. Drugs, 2006, 66 : 2213-2234.
  • 6Wu S H, Xiang K S, Zheng T S, et al. Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese [J]. Chin Med J, 2000, 113(5) : 437-441.
  • 7Kilpelainen T O, Lakka T A, Laaksonen D E, et al. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome : The finnish diabetes prevention study [J]. Metab Clin Exp, 2008, 57: 428-436.
  • 8Jerums G, Panagiotopoulos S, Premaratne E, et al. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropa- thy: A pooled analysis [J]. Am J Nephrol, 2008, 28: 614-627.
  • 9Ayodele O E, Alebiosu C O, Salako B L. Diabetic nephropathy -a review of the natural history, burden, risk factors and treatment [J]. J Natl Med Assoc, 2004, 96: 1445-1454.
  • 10Wu C, Lu H, Cassis LA, et al. Molecular and pathophysiological features of angiotensinogen: a mini review [J]. N Am J Med Sei (Boston) ,2011,4(4) :183-190.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部